References

Escherichia coli O157.

10.1016/s0140-6736(10)60963-4 · 2010 · External reference

Shiga toxin-producing Escherichia coli and the hemolytic-uremic syndrome.

10.1056/nejmra2108739 · 2023 · External reference

Haemolytic uraemic syndrome.

10.1016/s0140-6736(22)01202-8 · 2022 · External reference

2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea.

10.1093/cid/cix669 · 2017 · External reference

Shiga toxin-producing Escherichia coli outbreak in Canadian daycare centers.

10.1001/jamanetworkopen.2026.1278 · 2026 · External reference

The epidemiological and clinical characteristics of the largest outbreak of enterohemorrhagic Escherichia coli in Korea.

10.3346/jkms.2023.38.e117 · 2023 · External reference

Outbreak of shiga toxin-producing Escherichia coli serotype O26: H11 infection at a child care center in Colorado.

10.1097/inf.0b013e3182457122 · 2012 · External reference

Family clusters of Shiga toxin-producing Escherichia coli infection: an overlooked source of transmission. Data from the ItalKid-Hus network.

10.1097/inf.0000000000002877 · 2021 · External reference

Outbreak of Escherichia coli O157:H7 in a child care center in Cook County, Illinois, with prolonged shedding and household transmission.

10.1016/j.ajic.2013.03.312 · 2013 · External reference

Outbreak of enterohemorrhagic Escherichia coli O157:H7 infection associated with minced meat cutlets consumption in Kanagawa, Japan.

10.7883/yoken.jjid.2017.495 · 2018 · External reference

Long-term survival of Shiga toxin-producing Escherichia coli O26, O111, and O157 in bovine feces.

10.1128/aem.65.11.5177-5181.1999 · 1999 · External reference

An improved multiplex real-time SYBR green PCR assay for analysis of 24 target genes from 16 bacterial species in fecal DNA samples from patients with foodborne illnesses.

10.7883/yoken.jjid.2015.027 · 2016 · External reference

New system for multilocus variable-number tandem-repeat analysis of the enterohemorrhagic Escherichia coli strains belonging to three major serogroups: O157, O26, and O111.

10.1111/j.1348-0421.2010.00252.x · 2010 · External reference

Screening policies for daycare attendees: lessons learned from an outbreak of E. coli O157:H7 in a daycare in Waterloo, Ontario.

10.1007/bf03403755 · 2008 · External reference

Shedding and exclusion from childcare in children with Shiga toxin-producing Escherichia coli, 2018-2022.

10.1017/s095026882400027x · 2024 · External reference

Shiga toxin-producing Escherichia coli in diarrheal stool of Swedish children: evaluation of polymerase chain reaction screening and duration of Shiga toxin shedding.

10.1093/jpids/piv003 · 2016 · External reference

Predicting hemolytic uremic syndrome and renal replacement therapy in Shiga toxin-producing Escherichia coli-infected children.

10.1093/cid/ciz432 · 2020 · External reference

Duration of shedding of verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England.

10.1017/s095026881300109x · 2014 · External reference

Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.

10.1136/bmjopen-2015-009933 · 2016 · External reference

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

10.1093/cid/cis299 · 2012 · External reference

Associations between hydration status, intravenous fluid administration, and outcomes of patients infected with Shiga toxin-producing Escherichia coli: a systematic review and meta-analysis.

10.1001/jamapediatrics.2016.2952 · 2017 · External reference

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

10.1007/s00467-016-3496-0 · 2017 · External reference

Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis.

10.1093/cid/ciw099 · 2016 · External reference

Impact of antibiotic treatment on hemolytic uremic syndrome risk in Escherichia coli O157 infections: a comprehensive systematic review and meta-analysis.

10.1007/s10096-025-05145-1 · 2025 · External reference

Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.

10.1097/inf.0b013e31823096a8 · 2012 · External reference

Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.

10.1016/j.jinf.2019.05.018 · 2019 · External reference

The Shiga toxin 2 production level in enterohemorrhagic Escherichia coli O157:H7 is correlated with the subtypes of toxin-encoding phage.

10.1038/srep16663 · 2015 · External reference

Risk of hemolytic uremic syndrome from antibiotic treatment of Escherichia coli O157:H7 colitis.

10.1001/jama.288.24.3110-jlt1225-2-1 · 2002 · External reference

Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts.

10.1093/oxfordjournals.aje.a010082 · 1999 · External reference

Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.

10.1046/j.1442-200x.1999.4121041.x · 1999 · External reference

Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection.

1999 · External reference

Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: a population-based matched case control study.

10.1371/journal.pone.0263349 · 2022 · External reference

A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection.

10.1016/j.ijantimicag.2015.08.006 · 2015 · External reference

The dilemma of antimicrobial treatment of Shiga toxin-producing Escherichia coli.

10.1097/inf.0000000000000425 · 2014 · External reference

2017 Infectious Diseases Society of America’s clinical practice guidelines for healthcare-associated ventriculitis and meningitis.

10.1093/cid/ciw861 · 2017 · External reference

European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014.

10.1097/mpg.0000000000000375 · 2014 · External reference

Risk factors associated with antibiotic prescriptions for cases of enteric pathogens in Canada, 2015-2019.

10.1017/s0950268824001365 · 2024 · External reference

Antimicrobial prescribing practices for enteric bacterial infections in an integrated health care system, Wisconsin, 2004-2017.

10.1016/j.jiph.2024.102613 · 2025 · External reference

Duration of shedding and secondary household transmission of Shiga toxin-producing Escherichia coli O26 during an outbreak in a childcare center, Oregon, October-December 2010.

10.1093/jpids/pis063 · 2012 · External reference

Cost-effectiveness of excluding children with Shiga toxin-producing Escherichia coli (STEC) from childcare settings until microbiological clearance compared to return to childcare settings before microbiological clearance.

10.1017/s0950268825000196 · 2025 · External reference

Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.

10.1093/cid/cis1218 · 2013 · External reference

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

10.1001/jama.2012.264 · 2012 · External reference

Antimicrobial therapy and shedding time of Shiga toxin-producing Escherichia coli.

10.1080/00365540802337059 · 2008 · External reference